Skip to Main Content

Advertisement

Skip Nav Destination

Abstract 5037: Distinct tumor-immune ecologies in NSCLC patients predict progression and define a clinical biomarker of therapy response

Cancer Res (2022) 82 (12_Supplement): 5037.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal